The Foundation has extended an offer of US$85,000 to an international consortium of DIPG researchers.

The Foundation has extended a second £90,000 grant to Dr Chris Jones at The Institute of Cancer Research for the study entitled ‘The role of ACVR1/ALK2 mutations in Diffuse Intrinsic Pontine Glioma'.

The Foundation has approved its first UK research grant of £90,000 to Dr Chris Jones at The Institute of Cancer Research to study the role of ACVR1/ALK2 mutations in DIPG.

The Foundation awards a grant of $180,000 to Dr Michelle Monje, Stanford University, to study a combinatorial approach to target cellular subpopulations in Diffuse Intrinsic Pontine Glioma.

The Foundation is proud to announce the award of $114,670 to Dr, Mark Souwidane for Enhanced Delivery (CED) for Diffuse Intrinsic Pontine Glioma.

The Foundation awards Oregon Health & Science University (and other institutions globally) an $8,800 Supplement for their Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.